ALPHATEC HOLDINGS, INC. (ATEC) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -49.24M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | (m) | |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | 524.06M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-49.24M | (m) | (m) | (m) | $524.06M | (m) |
| 2026-03-31 | $-60.42M | (m) | (m) | (m) | $508.57M | (m) |
| 2025-12-31 | $-82.13M | (m) | (m) | (m) | $498.53M | (m) |
| 2025-09-30 | $-97.13M | (m) | (m) | (m) | $484.49M | (m) |
| 2025-06-30 | $-114.90M | (m) | (m) | (m) | $469.38M | (m) |
| 2025-03-31 | $-137.12M | (m) | (m) | (m) | $463.61M | (m) |
| 2024-12-31 | $-136.17M | (m) | (m) | (m) | $450.20M | (m) |
| 2024-09-30 | $-157.18M | (m) | (m) | (m) | $439.78M | (m) |
| 2024-06-30 | $-161.84M | (m) | (m) | (m) | $421.99M | (m) |
| 2024-03-31 | $-176.39M | (m) | (m) | (m) | $396.55M | (m) |
| 2023-12-31 | $-173.40M | (m) | (m) | (m) | $374.08M | (m) |
| 2023-09-30 | $-163.59M | (m) | (m) | (m) | $351.88M | (m) |
| 2023-06-30 | $-160.20M | (m) | (m) | (m) | $336.42M | (m) |
| 2023-03-31 | $-146.09M | (m) | (m) | (m) | $321.80M | (m) |
| 2022-12-31 | $-146.97M | (m) | (m) | (m) | $300.01M | (m) |
| 2022-09-30 | $-150.09M | (m) | (m) | (m) | $284.79M | (m) |
| 2022-06-30 | $-150.24M | (m) | (m) | (m) | $270.32M | (m) |
| 2022-03-31 | $-150.24M | (m) | (m) | (m) | $258.32M | (m) |
| 2021-12-31 | $-128.06M | (m) | (m) | (m) | $229.27M | (m) |
| 2021-09-30 | $-106.95M | (m) | (m) | (m) | $202.30M | (m) |
| 2021-06-30 | $-84.69M | (m) | (m) | (m) | $176.19M | (m) |
| 2021-03-31 | $-60.10M | (m) | (m) | (m) | $142.00M | (m) |
| 2020-12-31 | $-58.86M | (m) | (m) | (m) | $129.16M | (m) |
| 2020-09-30 | $-56.33M | (m) | (m) | (m) | $120.00M | (m) |
| 2020-06-30 | $-55.06M | (m) | (m) | (m) | $110.97M | (m) |
| 2020-03-31 | $-54.32M | (m) | (m) | (m) | $108.62M | (m) |
| 2019-12-31 | $-47.28M | (m) | (m) | (m) | $101.71M | (m) |
| 2019-09-30 | $-40.47M | (m) | (m) | (m) | $91.24M | (m) |
| 2019-06-30 | $-36.41M | (m) | (m) | (m) | $83.28M | (m) |
| 2019-03-31 | $-32.54M | (m) | (m) | (m) | $76.25M | (m) |
| 2018-12-31 | $-22.44M | (m) | (m) | (m) | $72.51M | (m) |
| 2018-09-30 | $-18.35M | $92.63M | (m) | (m) | (m) | -19.81% |
| 2018-06-30 | $-12.08M | $92.73M | (m) | (m) | (m) | -13.03% |
| 2018-03-31 | $-6.27M | $95.07M | (m) | (m) | (m) | -6.60% |
| 2017-12-31 | $-9.00M | $101.74M | (m) | (m) | (m) | -8.85% |
| 2017-09-30 | $-12.46M | $102.55M | (m) | (m) | (m) | -12.15% |
| 2017-06-30 | $-15.75M | $106.16M | (m) | (m) | (m) | -14.84% |
| 2017-03-31 | $-15.33M | $114.02M | (m) | (m) | (m) | -13.45% |
| 2016-12-31 | $-15.38M | $120.25M | (m) | (m) | (m) | -12.79% |
| 2016-09-30 | $-10.41M | $178.84M | (m) | (m) | (m) | -5.82% |
| 2016-06-30 | $-175.66M | $178.55M | (m) | (m) | (m) | -98.38% |
| 2016-03-31 | $-177.32M | $181.39M | (m) | (m) | (m) | -97.75% |
| 2015-12-31 | $-172.44M | $185.28M | (m) | $17.77M | (m) | -93.07% |
| 2015-09-30 | $-163.66M | $191.90M | (m) | (m) | (m) | -85.28% |
| 2015-06-30 | $3.02M | $199.92M | (m) | (m) | (m) | 1.51% |
| 2015-03-31 | $7.69M | $206.45M | (m) | (m) | (m) | 3.72% |
| 2014-12-31 | $1.84M | $206.98M | (m) | $16.80M | (m) | 0.89% |
| 2014-09-30 | $-57.13M | $206.42M | (m) | (m) | (m) | -27.68% |
| 2014-06-30 | $-72.04M | $205.60M | (m) | $15.56M | (m) | -35.04% |
| 2014-03-31 | $-76.78M | $203.45M | (m) | $14.69M | (m) | -37.74% |
| 2013-12-31 | $-73.43M | $204.72M | (m) | $14.19M | (m) | -35.87% |
| 2013-09-30 | $-21.42M | $204.40M | (m) | $14.26M | (m) | -10.48% |
| 2013-06-30 | $-10.22M | $201.04M | (m) | $14.45M | (m) | -5.08% |
| 2013-03-31 | $-11.07M | $198.26M | (m) | $14.56M | (m) | -5.58% |
| 2012-12-31 | $-9.84M | $196.28M | (m) | $14.89M | (m) | -5.01% |
| 2012-09-30 | $-22.34M | $193.04M | (m) | $14.24M | (m) | -11.57% |
| 2012-06-30 | $-22.73M | $193.82M | (m) | $14.88M | (m) | -11.73% |
| 2012-03-31 | $-22.28M | $196.45M | (m) | $15.48M | (m) | -11.34% |
| 2011-12-31 | $-24.52M | $197.71M | (m) | $16.89M | (m) | -12.40% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-11.79M | $171.61M | (m) | $16.43M | (m) | -6.87% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $-10.19M | $120.62M | (m) | $13.49M | (m) | -8.44% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |